<DOC>
	<DOC>NCT00168896</DOC>
	<brief_summary>Comparison of two combination chemotherapies in the treatment of patients with SLCL</brief_summary>
	<brief_title>A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage</brief_title>
	<detailed_description>Comparison of two combination chemotherapies in the treatment of patients with SLCL The combination chemotherapies for this study are Carboplatin plus Irinotecan versus Carboplatin plus Etoposide.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>cytological or histological proven SCLC Stage I or II at 1st diagnosis no prior chemotherapy measurable tumor disease karnofsky performance 70 second malignancy ( except basal cell carcinoma, CA in situ Cervix uteri) NYHA III chronic diarrhea, obstructive bowel syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>SCLC</keyword>
</DOC>